StockData
Agenus Inc logo

Agenus Inc (AGEN) stock

AGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$6.29−0.44 (-6.54%)

Close on Nov 16, 2026Market cap $283.18MP/E –Yield –

Agenus total assets

Total assets on the balance sheet at the end of each period.

Agenus's total assets was $172.69M at Jun 30, 2026. For fiscal 2025 it was $226.80M, up 0.2% from the year before. Over ten years it grew -0.7% a year on average. The highest annual figure on record is $465.96M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$226.80M+0.2%
FY2024Dec 31, 2024$226.27M-27.9%
FY2023Dec 31, 2023$313.91M-24.1%
FY2022Dec 31, 2022$413.56M-11.2%
FY2021Dec 31, 2021$465.96M+117.2%
FY2020Dec 31, 2020$214.51M+38.1%
FY2019Dec 31, 2019$155.34M+13.9%
FY2018Dec 31, 2018$136.40M-1.4%
FY2017Dec 31, 2017$138.40M-11.8%
FY2016Dec 31, 2016$156.99M-35.2%
FY2015Dec 31, 2015$242.23M+225.0%
FY2014Dec 31, 2014$74.53M+113.9%
FY2013Dec 31, 2013$34.84M+19.7%
FY2012Dec 31, 2012$29.09M+46.9%
FY2011Dec 31, 2011$19.81M-35.9%
FY2010Dec 31, 2010$30.91M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$172.69M-6.8%
Q1 FY2026Mar 31, 2026$186.46M-6.9%
Q4 FY2025Dec 31, 2025$226.80M+0.2%
Q3 FY2025Sep 30, 2025$233.89M-1.9%
Q2 FY2025Jun 30, 2025$185.22M-36.7%
Q1 FY2025Mar 31, 2025$200.20M-22.0%
Q4 FY2024Dec 31, 2024$226.27M-27.9%
Q3 FY2024Sep 30, 2024$238.48M-28.9%
Q2 FY2024Jun 30, 2024$292.42M-23.8%
Q1 FY2024Mar 31, 2024$256.56M-37.9%
Q4 FY2023Dec 31, 2023$313.91M-24.1%
Q3 FY2023Sep 30, 2023$335.47M-21.8%
Q2 FY2023Jun 30, 2023$383.59M-15.9%
Q1 FY2023Mar 31, 2023$412.85M-6.4%
Q4 FY2022Dec 31, 2022$413.56M-11.2%
Q3 FY2022Sep 30, 2022$429.02M-2.0%
Q2 FY2022Jun 30, 2022$456.17M+137.2%
Q1 FY2022Mar 31, 2022$441.31M+87.9%
Q4 FY2021Dec 31, 2021$465.96M+117.2%
Q3 FY2021Sep 30, 2021$437.64M+114.0%
Q2 FY2021Jun 30, 2021$192.30M+3.5%
Q1 FY2021Mar 31, 2021$234.92M+30.5%
Q4 FY2020Dec 31, 2020$214.51M+38.1%
Q3 FY2020Sep 30, 2020$204.48M+17.0%
Q2 FY2020Jun 30, 2020$185.78M-10.1%
Q1 FY2020Mar 31, 2020$180.06M-26.8%
Q4 FY2019Dec 31, 2019$155.34M+13.9%
Q3 FY2019Sep 30, 2019$174.81M+34.0%
Q2 FY2019Jun 30, 2019$206.71M+56.7%
Q1 FY2019Mar 31, 2019$245.93M+88.0%
Q4 FY2018Dec 31, 2018$136.40M-1.4%
Q3 FY2018Sep 30, 2018$130.48M-12.6%
Q2 FY2018Jun 30, 2018$131.94M-25.2%
Q1 FY2018Mar 31, 2018$130.82M-35.6%
Q4 FY2017Dec 31, 2017$138.40M-11.8%
Q3 FY2017Sep 30, 2017$149.27M-14.6%
Q2 FY2017Jun 30, 2017$176.49M–
Q1 FY2017Mar 31, 2017$203.27M–
Q4 FY2016Dec 31, 2016$156.99M–
Q3 FY2016Sep 30, 2016$174.84M–

More Agenus figures

See a number that looks wrong?